Which has the lower trailing P/E, BTMD or DRIO?

DRIO has the lower trailing P/E: BTMD trades at 9.97 and DRIO at 8.78. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BTMD or DRIO?

Over the past five years, BTMD grew revenue faster — BTMD at a 10.52% CAGR versus DRIO at 10.10%.

Is BTMD or DRIO more profitable?

DRIO runs the higher net margin — BTMD at 3.19% versus DRIO at 322.77%.

How have BTMD and DRIO total returns compared?

Over the past 5 years, BTMD delivered -35.12% and DRIO delivered -52.92% annualized total return. Past performance doesn't predict future results.

biote Corp. (BTMD) vs DarioHealth Corp. (DRIO)

A side-by-side comparison of biote Corp. and DarioHealth Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BTMD

biote Corp.

$51M

$1.16HealthcareDelayed quote: Oct 6, 2026, 2:28 PM EDT

DRIO

DarioHealth Corp.

$44M

$6.06HealthcareDelayed quote: Oct 6, 2026, 2:07 PM EDT

Total return — BTMD vs DRIO

growth of $100 · dividends reinvested · last 5y

BTMD -88.9% (-35.5%/yr)DRIO -98.7% (-57.8%/yr)BTMD compounded faster over this window

Log scale — wide-divergence pair

BTMD DRIO

BTMD vs DRIO: by the numbers

•BTMD is the larger company ($51M vs $44M market cap).
•DRIO trades at the lower trailing earnings multiple (8.78 vs 9.97 P/E), one valuation lens rather than an overall verdict.
•DRIO converts more revenue to profit (322.77% vs 3.19% net margin).
•BTMD grew revenue faster over the past five years (10.52% vs 10.10% CAGR).

Metrics side by side

Valuation

Metric	BTMD	DRIO
P/E ratio	9.97	8.78
P/S ratio	0.28	2.11
P/B ratio	N/A	0.80
EV / EBITDA	9.07	N/A
FCF yield	38.37%	N/A

Profitability

Metric	BTMD	DRIO
Gross margin	71.46%	56.09%
Operating margin	18.50%	-163.94%
Net margin	3.19%	322.77%
ROE	N/A	123.04%
ROIC	13.63%	-78.42%

Growth (annualized)

Metric	BTMD	DRIO
Revenue CAGR (5Y)	10.52%	10.10%
EPS CAGR (5Y)	-25.90%	N/A
FCF CAGR (5Y)	3.81%	N/A
Total return CAGR (5Y)	-35.12%	-52.92%

Frequently asked

Which has the lower trailing P/E, BTMD or DRIO?: DRIO has the lower trailing P/E: BTMD trades at 9.97 and DRIO at 8.78. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BTMD or DRIO?: Over the past five years, BTMD grew revenue faster — BTMD at a 10.52% CAGR versus DRIO at 10.10%.
Is BTMD or DRIO more profitable?: DRIO runs the higher net margin — BTMD at 3.19% versus DRIO at 322.77%.
How have BTMD and DRIO total returns compared?: Over the past 5 years, BTMD delivered -35.12% and DRIO delivered -52.92% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BTMD analysis Full DRIO analysis Interactive comparison tool

Dig into the metrics

biote P/E ratio DarioHealth P/E ratio biote ROE DarioHealth ROE biote operating margin DarioHealth operating margin biote revenue growth DarioHealth revenue growth biote free cash flow DarioHealth free cash flow

biote & DarioHealth appear in these rankings

Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.